Websites Selling Lifitegrast 5% Solution in India
Based on the most recent evidence, lifitegrast 5% ophthalmic solution (Xiidra) is available in India and can be purchased through clinical trials conducted in Indian patients, but specific websites selling this medication in India are not identified in the available evidence. 1
Background on Lifitegrast 5% Solution
- Lifitegrast 5% ophthalmic solution (Xiidra) is FDA-approved for treating signs and symptoms of dry eye disease by blocking the interaction between lymphocyte function-associated antigen 1 (LFA-1) and intracellular adhesion molecule 1 (ICAM-1) 2
- The medication works by inhibiting T-cell activation and migration to target tissues in dry eye disease, effectively reducing inflammation 2, 3
- It has demonstrated efficacy in improving both signs (corneal and conjunctival staining) and symptoms (eye dryness score and ocular discomfort) of dry eye disease over a 3-month period 2, 4
Evidence of Lifitegrast Availability in India
- A 2025 randomized, double-blind, active-controlled trial was conducted specifically with Indian patients with dry eye disease, comparing lifitegrast 5% with carboxymethylcellulose 0.5% 1
- This study enrolled 370 eligible Indian patients, suggesting that lifitegrast 5% is available in India at least in clinical trial settings 1
- The study demonstrated significantly better outcomes with lifitegrast 5% compared to carboxymethylcellulose 0.5% in Indian patients across multiple measures including eye dryness score, ocular discomfort score, ocular surface disease index, and tear film break-up time 1
Important Considerations When Purchasing Lifitegrast
- Lifitegrast 5% is a prescription medication that should be used under proper medical supervision 2
- When purchasing medications online, patients should ensure they are using legitimate pharmacy websites to avoid counterfeit products 2
- The American Academy of Ophthalmology recommends lifitegrast 5% as part of a step-wise approach for managing moderate to severe dry eye disease, particularly for patients with inadequate response to artificial tears 2
Clinical Efficacy and Safety
- Lifitegrast has shown efficacy in clinical trials with improvements in both subjective symptoms and objective signs of dry eye disease 3, 4
- The medication appears safe over 12 months of use, though long-term effects beyond this period remain unknown 2
- Common adverse reactions include ocular discomfort, with studies reporting adverse reactions in approximately 31.4% of patients 4
- Lifitegrast has also shown efficacy in contact lens discomfort and inflammatory meibomian gland dysfunction 5, 6
Caution
- While the medication is being used in India as evidenced by clinical trials, patients should consult with their ophthalmologist before purchasing and using lifitegrast 5% solution 1
- Online purchases of prescription medications should be made only through legitimate, licensed pharmacy websites to ensure product authenticity and safety 2